ask="2.95"
ask_size="2200"
average_daily_volume="1010000"
bid="2.46"
bid_size="2200"
book_value="0.34"
change="+0.27"
change_from_200_day_moving_average="1.21"
change_from_50_day_moving_average="1.02"
change_from_52_week_high="-1.29"
change_From_52_week_low="1.81"
change_in_percent="+10.19%"
close="2.92"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-0.99"
eps_estimate_next_quarter="-0.34"
eps_estimate_next_year="-0.95"
ex_dividend_date="N/A"
float_shares="4532000"
high="2.95"
high_52_weeks="4.21"
last_trade_date="3/3/2017"
last_trade_price="2.92"
last_trade_size="3582"
last_trade_time="4:00pm"
low="2.61"
low_52_weeks="1.11"
market_capitalization="27.99M"
moving_average_200_day="1.71"
moving_average_50_day="1.90"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="8.00"
open="2.61"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+70.84%"
percent_change_from_50_day_moving_average="+53.89%"
percent_change_from_52_week_high="-30.64%"
percent_change_from_52_week_low="+163.06%"
previous_close="2.65"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.82"
price_per_sales="49.91"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.76"
stock_exchange="NCM"
symbol="EYEG"
volume="2012967"
weeks_range_52="1.11 - 4.21"
